🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Autoimmune Diseases of the Nervous System

DANIsh VASculitis Database (DANIVAS) NCT05935709n/a2 sites📍 Aarhus📍 Horsens Aarhus University Hospital A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases NCT06978647Phase 11 site📍 Beijing China Immunotech (Beijing) Biotechnology Co., Ltd. · Tests: YTS109 cell A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care NCT06538064n/a15 sites📍 Rancho Mirage📍 San Francisco📍 New Haven Takeda · Tests: No Intervention Clinical and Instrumental Treatment's Predictors in Subjects With Neurological Diseases Using G-EO Robotic System NCT05493514n/a1 site📍 Milan Fondazione Don Carlo Gnocchi ETS · Tests: Robotic Assisted Gait Training with G-EO system Genes and Environment in Multiple Sclerosis NCT01353547n/a5 sites📍 Bethesda📍 Boston📍 Boston Columbia University Antibody-mediated LGI1 Encephalitis: Symptoms, Biomarkers, and Mechanisms of the Chronic Phase of the Disease NCT06515106NA1 site📍 Barcelona Fundacion Clinic per a la Recerca Biomédica · Tests: Remote cognitive rehabilitation program Risk of Progressive Multifocal Leukoencephalopathy Among Patients With Multiple Sclerosis Exposed to Zeposia NCT07732907n/a1 site📍 Lawrenceville Bristol-Myers Squibb · Tests: Ozanimod BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases NCT06794008Phase 21 site📍 Beijing Peking University People's Hospital · Tests: BCMA-CD19 CAR-T therapy Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Walking, Balance, and Cognitive Functions in Individuals With Multiple Sclerosis NCT07507084NA1 site📍 Kütahya Kutahya Health Sciences University · Tests: Internal Focus Dual-Task Training, External Focus Dual-Task Training A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis NCT07189325Phase 31 site📍 Montpellier University Hospital, Montpellier · Tests: Platform therapies (Dimethyl Fumarate, Teriflunomide, Glatiramer Acetate, Beta-interferons), Anti-CD20 therapies (Ocrel… Prepare the Mind: Can Coaching in Goal-directed Behaviour Increase the Success of Cognitive Rehabilitation in People With MS? NCT07225868NA3 sites📍 Buffalo📍 Leiden📍 Rheinfelden Universiteit Leiden · Tests: Conscientiousness Coaching Before Cognitive Rehabilitation, Sham Intervention Before Cognitive Rehabilitation A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases NCT06980597Phase 12 sites📍 Beijing📍 Beijing Beijing GoBroad Hospital · Tests: OL-108 Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis NCT03993262Phase 217 sites📍 München📍 Würzburg📍 Jena Jena University Hospital · Tests: Bortezomib, Placebo Treatment of Moderate to Severe Refractory Crohn's Disease NCT06721962Phase 1, Phase 213 sites📍 Scottsdale📍 Sacramento📍 San Francisco Tr1X, Inc. · Tests: TRX103, Cyclophosphamide Blood Flow Restriction And Veterans With MS NCT05433103NA1 site📍 Aurora VA Office of Research and Development · Tests: Low-Load Exercise with Blood Flow Restriction, Low-Load Exercise Control Group Solriamfetol for the Treatment of Multiple Sclerosis Fatigue NCT06170970Phase 21 site📍 Baltimore Johns Hopkins University · Tests: Solriamfetol, Placebo Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod NCT07072988Phase 49 sites📍 Nice📍 Créteil📍 Garches Centre Hospitalier Universitaire de Nice · Tests: Efgartigimod Impact of TTNS on Bladder Symptoms Among People With MS, A RCT NCT06341673NA1 site📍 Khobar Hawra Al-Dandan · Tests: Active Transcutaneous Electrical Nerve Stimulation (TENS), Sham Transcutaneous Electrical Nerve Stimulation (TENS) The VGR GCA Cohort: Ultrasound, Biopsy and Biomarkers - Novel Methods for Diagnosis, Monitoring and Prognosis in Giant Cell Arteritis. NCT07246577n/a1 site📍 Gothenburg Vastra Gotaland Region CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases NCT06941129Phase 11 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: UCAR T-cell Integrating Metabolism, Connectivity, and Mesoscale Imaging at Ultra-high Field to Decipher Mechanisms of Resilience and Neurodegeneration in Neurological Diseases and Healthy Aging NCT07202494n/a1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Imaging Techniques (MRI 3T & 7T, Functional, Structural, and Metabolic Imaging) Prevalence and Impact of Obstructive Sleep Apnea in Multiple Sclerosis NCT04603196n/a1 site📍 Boston Beth Israel Deaconess Medical Center Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG) NCT07215650Phase 110 sites📍 Fuzhou📍 Guangzhou📍 Guangzhou Candid Therapeutics · Tests: Cizutamig A Study to Evaluate the Preliminary Efficacy and Safety of Terfenadine in Patients With Relapsing-Remitting Multiple Sclerosis NCT07827716Phase 21 site📍 Wuhan Chuan Qin · Tests: Terfenadine, Standard First-line Disease-Modifying Therapy A Phase 1 Open-label Study to Evaluate Safety in Healthy Participants and Participants With Autoimmune Diseases NCT07284797Phase 11 site📍 Melbourne Xencor, Inc. · Tests: XmAb657 Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions NCT04833465n/a1 site📍 Washington D.C. Children's National Research Institute · Tests: No Intervention From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis NCT04873492NA1 site📍 Nantes Nantes University Hospital · Tests: Biological sample collection Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD NCT06780709NA1 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Wellness Program and Behavioral Counseling Adult Autoimmune Myopathies (MAIA) NCT04792931NA1 site📍 Brest University Hospital, Brest · Tests: description of adult autoimmune myopathies
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy